Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells

Published:2015-05 Issue:2 Volume:95 Page:98-109
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wang Siyuan,Mou Zhenzhen,Ma Yuanheng,Li Jian,Li Jingyun,Ji Xiwei,Wu Kehua,Li Liang,Lu Wei,Zhou Tianyan

Funder

National Natural Science Foundation of China

Pfizer

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference46 articles.

1. Cancer statistics, 2014;Siegel;CA: Cancer J. Clin.,2014

2. Novel strategies towards the use of anti-angiogenic agents in breast cancer;Bakker;Eur. J. Pharmacol.,2013

3. Drug insight VEGF as a therapeutic target for breast cancer;Schneider;Nat. Clin. Pract. Oncol.,2007

4. Antiangiogenic therapy of breast cancer. How did we get here? The road not taken;Alba;Clin. Transl. Oncol.,2011

5. Angiogenesis as a therapeutic target in breast cancer;Koutras;Mini-Rev. Med. Chem.,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Dopamine on stem cells and its potential roles in the treatment of inflammatory disorders: a narrative review;Stem Cell Research & Therapy;2023-08-30

2. The tumor-nerve circuit in breast cancer;Cancer and Metastasis Reviews;2023-03-31

3. Application of a count data model to evaluate the anti-metastatic efficacy of QAP14 in 4T1 breast cancer allografts;Journal of Theoretical Biology;2023-01

4. Exploring neurotransmitters and their receptors for breast cancer prevention and treatment;Theranostics;2023

5. Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells;Translational Oncology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3